Hasil Pencarian (1)
Odronextamab
DB16684
biotech | CAS: 1801338-64-6
Odronextamab is a hinge-stabilized, fully human immunoglobulin G4 (IgG4)-based CD20×CD3 bispecific antibody currently evaluated for the treatment of relapsed/refractory (R/R) B-Cell non-Hodgkin lymphoma (NHL).[A254187,A254197] Preliminary studies have shown t…
Target Protein:
B-lymphocyte antigen CD20T-cell surface glycoprotein CD3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik
-